Silverdene Medical Limited 13997668 false 2023-04-01 2024-03-31 2024-03-31 The principal activity of the company is Specialist medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true 13997668 2023-04-01 2024-03-31 13997668 2024-03-31 13997668 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 13997668 bus:Micro-entities 2023-04-01 2024-03-31 13997668 bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 13997668 bus:FilletedAccounts 2023-04-01 2024-03-31 13997668 bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 13997668 bus:RegisteredOffice 2023-04-01 2024-03-31 13997668 bus:Director1 2023-04-01 2024-03-31 13997668 bus:Director2 2023-04-01 2024-03-31 13997668 bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 13997668 countries:AllCountries 2023-04-01 2024-03-31 13997668 2022-03-23 2023-03-31 13997668 2023-03-31 13997668 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 iso4217:GBP xbrli:pure

Silverdene Medical Limited

Annual Report and Unaudited Financial Statements
Year Ended 31 March 2024

Registration number: 13997668

 

Silverdene Medical Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Silverdene Medical Limited

Company Information

Directors

Dr Robert Hartley

Dr Ruth Hartley

Registered office

Lowin House
Tregolls Road
Truro
Cornwall
TR1 2NA

Accountants

PKF Francis Clark
Chartered Accountants
Lowin House
Tregolls Road
Truro
Cornwall
TR1 2NA

 

Silverdene Medical Limited

Balance Sheet

31 March 2024

2024
£

2023
£

Fixed assets

552

143

Current assets

42,453

20,428

Creditors: Amounts falling due within one year

(7,491)

(5,502)

Net current assets

34,962

14,926

Total assets less current liabilities

35,514

15,069

Accruals and deferred income

(1,440)

(1,740)

 

34,074

13,329

Capital and reserves

34,074

13,329

1

General information

The address of its registered office is:
Lowin House
Tregolls Road
Truro
Cornwall
TR1 2NA
UK

These financial statements were authorised for issue by the Board on 18 October 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2023 - 0).

For the financial year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

Silverdene Medical Limited

Balance Sheet

31 March 2024

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS105 The Financial Reporting Standard applicable to the Micro-entities Regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 18 October 2024 and signed on its behalf by:
 

.........................................
Dr Robert Hartley
Director

   
     
 

Silverdene Medical Limited

Detailed profit and loss

Year Ended 31 March 2024

Year ended 31 March 2024
 £

23 March 2022 to 31 March 2023
 £

Turnover

Rendering of services

40,583

30,647

Gross profit (%)

100%

100%

Administrative expenses

Administrative expenses

(2,715)

(1,917)

Operating profit

37,868

28,730

Profit before tax

37,868

28,730

 

Silverdene Medical Limited

Detailed profit and loss

Year Ended 31 March 2024

Year ended 31 March 2024
£

23 March 2022 to 31 March 2023
£

Administration costs

Use of home as office

504

-

Sundry expenses

400

50

Staff entertaining (allowable for tax)

85

91

Accountancy fees

1,560

1,740

Legal and professional fees

13

-

Bank charges

6

-

Depreciation of office equipment (owned)

147

36

2,715

1,917